Metabolic memory underlying minimal residual disease in breast cancer
Abstract Tumor relapse from treatment‐resistant cells (minimal residual disease, MRD) underlies most breast cancer‐related deaths. Yet, the molecular characteristics defining their malignancy have largely remained elusive. Here, we integrated multi‐omics data from a tractable organoid system with a...
Saved in:
| Main Authors: | Ksenija Radic Shechter, Eleni Kafkia, Katharina Zirngibl, Sylwia Gawrzak, Ashna Alladin, Daniel Machado, Christian Lüchtenborg, Daniel C Sévin, Britta Brügger, Kiran R Patil, Martin Jechlinger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2021-10-01
|
| Series: | Molecular Systems Biology |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/msb.202010141 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unravelling the pathways driving tumour growth and resistance
by: Abraham Ubhenin, et al.
Published: (2025-06-01) -
Transcriptomic and proteomic sequencing unveils the role of vitamin D and metabolic flux shifts in the induction of human hepatic organoids
by: Shule Zhang, et al.
Published: (2024-12-01) -
Establishment of Stable Knockdown of MACC1 Oncogene in Patient-Derived Ovarian Cancer Organoids
by: Sophia Hierlmayer, et al.
Published: (2024-12-01) -
Adaptive laboratory evolution of microbial co‐cultures for improved metabolite secretion
by: Dimitrios Konstantinidis, et al.
Published: (2021-08-01) -
Advances in humanoid organoid-based research on inter-organ communications during cardiac organogenesis and cardiovascular diseases
by: Baoqiang Ni, et al.
Published: (2025-03-01)